首页> 外文OA文献 >A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

【2h】

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

机译：ELESCLOMOL钠和每周紫杉醇治疗复发性或持久性铂卵巢，输卵管或原发性腹膜癌的II期评价：NRG肿瘤学/妇科肿瘤学群体研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Bradley J. Monk; James T. Kauderer; Katherine M. Moxley; Albert J. Bonebrake; Summer B. Dewdney; Angeles Alvarez Secord; Frederick R. Ueland; Carolyn M. Johnston; Carol Aghajanian;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study [J] . Bradley J. Monk, James T. Kauderer, Katherine M. Moxley, Gynecologic Oncology: An International Journal . 2018,第3期

机译：ELESCLOMOL钠和每周紫杉醇治疗复发性或持久性铂卵巢，输卵管或原发性腹膜癌的II期评价：NRG肿瘤学/妇科肿瘤学群体研究
2. A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study [J] . Matulonis Ursula A., Sill Michael W., Makker Vicky, Gynecologic Oncology: An International Journal . 2019,第3期

机译：Cabozantib的随机阶段II研究与每周紫杉醇治疗持续或复发上皮卵巢，输卵管或原发性腹膜癌：NRG肿瘤学/妇科肿瘤学群体研究
3. A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study. [J] . Coleman RL, Brady WE, McMeekin DS, Gynecologic Oncology: An International Journal . 2011,第1期

机译：妇科肿瘤学小组研究：对复发性或持续性铂耐药性卵巢癌，输卵管癌或原发性腹膜癌的纳米粒子，白蛋白结合的紫杉醇的II期评估。
4. Sodium selenite in gynecologic radiation oncology. Results of a phase III study [C] . Muecke, R., Glatzel, Workshop on Macro, Trace and Ultratrace Elements; 20040924-25; Jena(DE) . 2004

机译：亚硒酸钠在妇科放射肿瘤学中的应用。第三阶段研究的结果
5. Analysis of Oncologic Outcomes Associated with Anti-adhesion Sodium Hyaluronate-Carboxymethylcellulose Barrier Following Optimal or Complete Cytoreductive Surgery for Ovarian, Fallopian Tube, and Peritoneal Cancers. [D] . Krill, Lauren. 2014

机译：卵巢癌，输卵管癌和腹膜癌的最佳或完全细胞还原手术后，与抗粘连透明质酸钠-羧甲基纤维素屏障相关的肿瘤学结果分析。
6. A phase II evaluation of nanoparticle albumin-bound (nab) paclitaxel) in the treatment of recurrent or persistent platinum-resistant ovarian fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study [O] . Robert L. Coleman, William E. Brady, D. Scott McMeekin, -1

机译：纳米粒子白蛋白结合（NAB）紫杉醇的II期评价在治疗复发性或持续铂卵巢卵巢输卵管或原发性腹膜癌中的治疗方法：妇科肿瘤学群体研究
7. A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study [O] . Ursula A. Matulonis, Michael W. Sill, Vicky Makker, 2019

机译：Cabozantib的随机期II研究与每周紫杉醇治疗持续或复发上皮卵巢，输卵管或原发性腹膜癌：NRG肿瘤学/妇科肿瘤学群体研究

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

著录项

引文网络

相似文献

相关主题

期刊订阅